Welcome to our dedicated page for Argan SEC filings (Ticker: AGX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Argan, Inc. (NYSE: AGX) is a Delaware corporation whose common stock is listed on the New York Stock Exchange, and it files periodic and current reports with the U.S. Securities and Exchange Commission. This SEC filings page brings together Argan’s Forms 10-K and 10-Q, as well as its frequent Form 8-K current reports, which disclose material events such as financial results, major project contracts and dividend declarations.
In its Form 8-K filings, Argan reports items like quarterly earnings releases under results of operations and financial condition, regular quarterly cash dividend announcements, and significant EPC contract awards received by subsidiaries such as Gemma Power Systems and Atlantic Projects Company. These filings also confirm key corporate details, including Argan’s state of incorporation, the AGX trading symbol and its New York Stock Exchange listing.
For investors and analysts, Argan’s annual reports on Form 10-K and quarterly reports on Form 10-Q provide more comprehensive information on segment performance, project backlog, risk factors and accounting policies, while current reports on Form 8-K highlight specific developments between reporting periods. Filings may also describe how new EPC contracts, full notices to proceed and backlog additions affect the company’s future activity.
On this page, AI-powered tools summarize lengthy SEC documents, highlight the main points from Argan’s 10-K and 10-Q filings, and explain the significance of individual 8-K items, such as dividend changes or large contract awards. Users can also review insider and executive-related filings like Form 4, along with proxy materials, to gain additional insight into Argan’s governance and equity activity.
Argan, Inc. director John R. Jeffrey, Jr. reported equity compensation activity involving time-based restricted stock units that converted into common stock. On 12/14/2025, 856 shares of common stock were acquired at $0 per share, bringing his directly held stake to 5,412 shares. On 12/16/2025, he acquired a further 1,844 common shares at $0, increasing his direct holdings to 7,256 shares. Footnotes explain that these issuances came from three-year time-based restricted stock unit awards granted on 12/14/2023 and 12/16/2022, with share amounts adjusted for dividends. The filing also shows 8,000 common shares held indirectly through a John R. Jeffrey, IRA, and remaining time-based restricted stock units listed as derivative securities.
Argan Inc. director James W. Quinn reported the vesting and settlement of time-based restricted stock units into common shares. On December 14, 2025, 856 common shares were acquired at an exercise price of $0, increasing his direct holdings to 5,434 shares. On December 16, 2025, he acquired a further 1,844 shares at $0, bringing his direct ownership to 7,278 shares.
The underlying awards were Time-Based Restricted Stock Units awarded on December 14, 2023 and December 16, 2022, each with a three-year vesting schedule. According to the disclosure, 833 and 1,750 shares of common stock became issuable on December 14 and December 16, 2025, respectively, with amounts adjusted for dividends. Following these transactions, Quinn also reported indirect ownership of 43,992 shares held by the James W. Quinn 2025 GRAT No.1 and continued holdings of 3,114 and 1,364 Time-Based Restricted Stock Units.
Argan Inc director Peter W. Getsinger reported that time-based restricted stock unit awards vested and converted into common stock in two transactions during December 2025.
The awards, originally granted in December 2022 and December 2023, followed three-year vesting schedules, after which shares of Argan common stock became issuable to him at an exercise price of $0.
After these transactions, he directly owned 12,597 shares of common stock and held 1,364 time-based restricted stock units as ongoing stock-based compensation.
Argan Inc. director reports vested equity awards. On 12/14/2025 and 12/16/2025, the reporting person acquired 856 and 1,844 shares of Argan Inc. common stock at a price of $0 following the exercise of derivative awards, bringing direct ownership to 19,128 common shares.
The transactions relate to time-based restricted stock units awarded on 12/14/2023 and 12/16/2022, under which 833 and 1,750 shares of common stock became issuable on the respective 2025 vesting dates, adjusted for dividends. After these settlements, the director continues to hold 3,114 and 1,364 time-based restricted stock units as derivative securities.
Argan Inc. director William F. Leimkuhler reported stock awards vesting that increased his direct ownership of the company’s common shares. On December 14, 2025, 856 shares of common stock were acquired at $0 per share following the vesting of time-based restricted stock units awarded earlier. On December 16, 2025, a further 1,844 shares were acquired at $0 per share from another time-based restricted stock unit award.
After these transactions, Leimkuhler directly beneficially owned 41,534 shares of Argan Inc. common stock. He also continues to hold time-based restricted stock units, with 3,114 units remaining from the 2023 award and 1,364 units remaining from the 2022 award.
Argan Inc. director James W. Quinn reported recent gifts and sales of company stock. On December 9, 2025, he gifted 1,000 shares of Argan common stock to The Quinn Family Fund, a donor-advised fund, at a reported price of $0 per share. Following that transaction, he directly held 4,578 shares and The Quinn Family Fund held 1,000 shares indirectly attributed to him.
On December 10, 2025, The Quinn Family Fund sold its 1,000 shares of Argan common stock on the open market at $328.04 per share, leaving it with 0 shares. The filing also reports an additional 43,992 shares of Argan common stock held indirectly through the James W. Quinn 2025 GRAT No.1.
Argan, Inc. announced that its Board of Directors has declared a regular quarterly cash dividend of $0.50 per share of common stock. The dividend will be paid on January 30, 2026 to stockholders who are on record as of the close of business on January 22, 2026. This reflects the company’s ongoing practice of returning cash to shareholders through regular dividends.
Argan Inc. director and non-executive chairman William F. Griffin, Jr. reported an internal share transfer between his affiliated trusts. On December 5, 2025, 140,976 shares of Argan common stock were moved from the William F Griffin Jr. Revocable Trust to the William F Griffin 2025 GRAT Trust at a reported price of $0 per share. Following the transaction, the revocable trust no longer held these shares and the 2025 GRAT trust held 140,976 shares indirectly on his behalf.
Argan, Inc. (AGX) reported solid third‑quarter results for the period ended October 31, 2025. Quarterly revenues were $251.2 million, slightly below $257.0 million a year ago, but profitability improved. Net income rose to $30.7 million from $28.0 million, and diluted earnings per share increased to $2.17 from $2.00. Gross profit expanded to $46.9 million from $44.3 million as project mix and execution boosted margins.
For the first nine months of the year, revenues grew to $682.6 million from $641.7 million, while net income climbed to $88.6 million from $54.1 million, lifting diluted EPS to $6.27 from $3.91. Cash and cash equivalents more than doubled to $306.3 million, and total investments reached $420.5 million, supporting a strong balance sheet with no borrowings on the $35.0 million credit facility. The company increased its quarterly dividend by 33% to $0.50 per share and expanded project backlog to $3.0 billion, largely in natural gas and renewable power projects.
Argan, Inc. reported that it has released its financial results for the three months ended October 31, 2025. The company announced these quarterly results through a press release dated December 4, 2025, which is attached as an exhibit to this report. The press release contains the detailed financial information and discussion of Argan’s operating performance for the period.